News and Trends 29 Sep 2025 First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics? FDA approval for Stealth BioTherapeutics’ elamipretide has been a long time coming. What does this mean for other ultra-rare disease companies? September 29, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 9 Sep 2025 Top biotech deals in August 2025 Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small molecules. September 9, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 Aug 2025 Top biotech deals in July 2025 Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery. August 8, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2025 Top biotech deals in June 2025 Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and immunotherapies. July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Reports 2 Jul 2025Artificial intelligence and the future of antibody discovery Discover how AI and ML are already shaping therapeutic antibody discovery and explore their future potential. July 2, 2025 Share WhatsApp Twitter Linkedin Email
In Depth 13 Jun 2025 A new era in migraine treatment: Innovative drugs redefining the field Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for the better. June 13, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jun 2025 ASCO 2025: key highlights in cancer therapeutics Discover the major highlights from ASCO, according to researchers and drug developers who attended the convention. June 4, 2025 - 18 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 3 Jun 2025 How biotechs are developing novel treatments to tackle high cholesterol Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets. June 3, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jun 2025 Top biotech deals in May 2025 Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and antibodies. June 2, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Mar 2025 Top biotech deals of February 2025 Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations. March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 10 Feb 2025 Monoclonal antibodies: are they the key to treating Alzheimer’s disease? A major stride in treating Alzheimer’s disease has been the development of monoclonal antibodies. February 10, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2025 Top biotech deals of January 2025 January 2025 kicked off in full swing with several biotech deals in the biopharma industry. February 6, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email